About Us

Our core team combines biopharma science, BD&L and business process, biopharma data/analytics leadership, and tech startup experience.


Diviner Org

Mark Gordon

Founder and CEO

20 years experience helping biotech and pharma companies apply data, analytics and technology in R&D and BD&L
Diviner Org

Jason Kralic


PhD Neuroscientist with 16 years BD&L experience in industry, startups and academia
Diviner Org

Dan Mytelka

Head of Methodology

PhD in Genetics / Biochemistry, MBA in Finance, 18 years with Lilly
Diviner Org

Ted Benson

Head of Operations

20 years of experience in biotech & biopharma: drove scientific and business results
Diviner Org

James Chen

Associate Portfolio Manager

CFA Charterholder with 10+ years of experience in equity research covering therapeutics on the sellside, buyside and industry. Studied finance at NYU Stern and molecular biology at UC Berkeley
Diviner Org

John Kenan

Project Management

20 years leading projects in Marketing and IT
Diviner Org

Mike Gogis

Fractional CFO

Certified Public Accountant serving various companies as strategic CFO
Diviner Org

Mike Dombeck


Chief Operating Officer, Arcellx, Clinical-Stage adaptable and controllable cell therapies for cancer and autoimmune diseases.
Diviner Org

June Almenoff


MD/PhD/FACP. Holds C-Level Executive Roles including various advisory, consulting and board positions with biotech, biopharma and clinical-stage therapeutics.
Diviner Org

Connie Pobanz

Executive Assistant

Small business owner, 10 years